» Articles » PMID: 11085810

Phenotype-genotype Correlation in 91 Patients with Familial Mediterranean Fever Reveals a High Frequency of Cutaneomucous Features

Overview
Specialty Rheumatology
Date 2000 Nov 21
PMID 11085810
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To describe the clinical manifestations of familial Mediterranean fever (FMF) in 91 patients from 47 families and provide data from the genetic study. P:atients and methods. We conducted a retrospective chart review of 91 patients (including 83 children aged <15 yr) from 47 families through a questionnaire and a specific database. The genetic analysis included complete screening of known mutations of the MEFV gene on chromosome 16p13.3. A positive diagnosis required at least two mutations, one on each chromosome.

Results: Our panel included 52 females and 39 males, with a mean age of 7.27 yr. Of the 47 families, 31 were non-Ashkenazi Jews, 10 were Armenians and six were from other ethnic groups. Clinical features included fever (100%), peritonitis (86%), pleuritis (56%), arthritis (34%) and myalgias (27%). We observed a high rate of cutaneous manifestations (47%); erythema, oedema and recurrent oral ulcers were the most frequent. Phenotype-genotype correlations showed a significant association of M694V homozygosity with earlier age of onset (P: = 0.044), fever >39 degrees C (P: = 0. 002), pleural crisis (P: = 0.0044), splenomegaly (P: = 0.0005) and arthritis (P: = 0.001). Associations with mucocutaneous features were as follows: erysipelas-like erythema (P: = 0.012), oedema (P: = 0.61, not significant) and oral ulcers (P: = 0.45, not significant).

Conclusion: New phenotype-genotype correlations emerged from our study: homozygosity for the M694V mutation was associated with intensity of fever, splenomegaly and with erysipelas-like erythema. Apart from erysipelas-like erythema, no significant association was found between other cutaneous features and the genotype.

Citing Articles

Phenotype-genotype correlation in children with familial Mediterranean fever in Morocco.

Souali M, Sakhi A, Bousfiha A, Bouayed K Qatar Med J. 2024; 2024(3):41.

PMID: 39588206 PMC: 11577442. DOI: 10.5339/qmj.2024.41.


An Update on Familial Mediterranean Fever.

Lancieri M, Bustaffa M, Palmeri S, Prigione I, Penco F, Papa R Int J Mol Sci. 2023; 24(11).

PMID: 37298536 PMC: 10253709. DOI: 10.3390/ijms24119584.


Recurrent Fever with Oral Lesions in Egyptian Children: A Familial Mediterranean Fever Diagnosis Not to Be Missed.

Omran A, Abdelrahman A, Mohamed Y, Abdalla M, Abdel-Hamid E, Elfiky S Children (Basel). 2022; 9(11).

PMID: 36360382 PMC: 9689065. DOI: 10.3390/children9111654.


Efficacy and safety of long-term treatment with intravenous colchicine for familial Mediterranean fever (FMF) refractory to oral colchicine.

Grossman C, Farberov I, Feld O, Livneh A, Ben-Zvi I Rheumatol Int. 2019; 39(3):517-523.

PMID: 30604205 DOI: 10.1007/s00296-018-04237-w.


Association of amyloidosis cutis dyschromica and familial Mediterranean fever.

Akin Belli A, Kara A, Dere Y, Yilmaz N An Bras Dermatol. 2017; 92(5 Suppl 1):21-23.

PMID: 29267436 PMC: 5726667. DOI: 10.1590/abd1806-4841.20176114.